ID   NHRF1_RAT               Reviewed;         356 AA.
AC   Q9JJ19;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUL-2024, entry version 178.
DE   RecName: Full=Na(+)/H(+) exchange regulatory cofactor NHE-RF1;
DE            Short=NHERF-1;
DE   AltName: Full=Ezrin-radixin-moesin-binding phosphoprotein 50;
DE            Short=EBP50;
DE   AltName: Full=Regulatory cofactor of Na(+)/H(+) exchanger;
DE   AltName: Full=Sodium-hydrogen exchanger regulatory factor 1;
DE   AltName: Full=Solute carrier family 9 isoform A3 regulatory factor 1;
GN   Name=Nherf1; Synonyms=Nherf, Slc9a3r1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND DIMERIZATION.
RC   TISSUE=Liver;
RX   PubMed=10859298; DOI=10.1074/jbc.c000092200;
RA   Fouassier L., Yun C.H.C., Fitz J.G., Doctor R.B.;
RT   "Evidence for ezrin-radixin-moesin-binding phosphoprotein 50 (EBP50) self-
RT   association through PDZ-PDZ interactions.";
RL   J. Biol. Chem. 275:25039-25045(2000).
RN   [2]
RP   INTERACTION WITH PODXL.
RX   PubMed=11457882; DOI=10.1172/jci12539;
RA   Takeda T., McQuistan T., Orlando R.A., Farquhar M.G.;
RT   "Loss of glomerular foot processes is associated with uncoupling of
RT   podocalyxin from the actin cytoskeleton.";
RL   J. Clin. Invest. 108:289-301(2001).
RN   [3]
RP   INTERACTION WITH SLC4A7.
RX   PubMed=12444018; DOI=10.1152/ajpcell.00225.2002;
RA   Pushkin A., Abuladze N., Newman D., Muronets V., Sassani P., Tatishchev S.,
RA   Kurtz I.;
RT   "The COOH termini of NBC3 and the 56-kDa H+-ATPase subunit are PDZ motifs
RT   involved in their interaction.";
RL   Am. J. Physiol. 284:C667-C673(2003).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-277; SER-287; SER-288;
RP   THR-290; SER-291 AND SER-299, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Scaffold protein that connects plasma membrane proteins with
CC       members of the ezrin/moesin/radixin family and thereby helps to link
CC       them to the actin cytoskeleton and to regulate their surface
CC       expression. Necessary for recycling of internalized ADRB2. Was first
CC       known to play a role in the regulation of the activity and subcellular
CC       location of SLC9A3. Necessary for cAMP-mediated phosphorylation and
CC       inhibition of SLC9A3. Involved in sperm capacitation. May participate
CC       in the regulation of the chloride and bicarbonate homeostasis in
CC       spermatozoa. May enhance Wnt signaling. May participate in HTR4
CC       targeting to microvilli (By similarity). Involved in the regulation of
CC       phosphate reabsorption in the renal proximal tubules (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with NHERF2. Binds the N-termini of
CC       EZR, RDX and MSN. Binds the C-termini of PDGFRA, PDGFRB, ADRB2, NOS2
CC       and CFTR. Binds ARHGAP17, EPI64, RACK1, OPRK1, GNAQ, CTNNB1 and PLCB3.
CC       Binds PDZK1 (By similarity). Interacts with CLCN3. Binds the C-terminus
CC       of PAG1. In resting T-cells, part of a PAG1-NHERF1-MSN complex which is
CC       disrupted upon TCR activation. Forms a complex with CFTR and SLC4A7.
CC       Forms a complex with SLC4A7 and ATP6V1B1. Interacts with TRPC4 (via the
CC       PDZ-binding domain). Directly interacts with HTR4 (By similarity).
CC       Interacts (via the PDZ 1 domain) with PODXL (via the C-terminal PDZ-
CC       binding motif DTHL); interaction is not detected in glomerular
CC       epithelium cells. Interacts (via the PDZ 1 domain) with PODXL (via the
CC       C-terminal PDZ-binding motif DTHL); the interaction take place early in
CC       the secretory pathway and is necessary for its apical membrane sorting
CC       (By similarity). Interacts with SLC26A3 (By similarity). Interacts with
CC       MCC. Interacts with SLC34A1. Interacts (via the PDZ domains) with
CC       SLC26A6 isoform 4 and isoform 5 (By similarity). Interacts (via PDZ
CC       domains) with ACE2 (via PDZ-binding motif); the interaction may enhance
CC       ACE2 membrane residence (By similarity). {ECO:0000250|UniProtKB:O14745,
CC       ECO:0000250|UniProtKB:P70441}.
CC   -!- INTERACTION:
CC       Q9JJ19; O35240: Asic3; NbExp=5; IntAct=EBI-982391, EBI-982374;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Apical cell membrane
CC       {ECO:0000250}. Cell projection, filopodium {ECO:0000250}. Cell
CC       projection, ruffle {ECO:0000250}. Cell projection, microvillus
CC       {ECO:0000250}. Endomembrane system {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}. Note=Colocalizes with actin in microvilli-rich
CC       apical regions of the syncytiotrophoblast. Present in lipid rafts of T-
CC       cells. Translocates from the cytoplasm to the apical cell membrane in a
CC       PODXL-dependent manner. Colocalizes with CFTR at the midpiece of sperm
CC       tail (By similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF154336; AAF73258.1; -; mRNA.
DR   RefSeq; NP_067605.1; NM_021594.1.
DR   AlphaFoldDB; Q9JJ19; -.
DR   SMR; Q9JJ19; -.
DR   BioGRID; 248735; 3.
DR   IntAct; Q9JJ19; 2.
DR   STRING; 10116.ENSRNOP00000004351; -.
DR   iPTMnet; Q9JJ19; -.
DR   PhosphoSitePlus; Q9JJ19; -.
DR   SwissPalm; Q9JJ19; -.
DR   jPOST; Q9JJ19; -.
DR   PaxDb; 10116-ENSRNOP00000004351; -.
DR   Ensembl; ENSRNOT00000004351.5; ENSRNOP00000004351.1; ENSRNOG00000003232.5.
DR   Ensembl; ENSRNOT00065036648; ENSRNOP00065029495; ENSRNOG00065021568.
DR   GeneID; 59114; -.
DR   KEGG; rno:59114; -.
DR   AGR; RGD:708538; -.
DR   CTD; 9368; -.
DR   RGD; 708538; Nherf1.
DR   eggNOG; KOG3528; Eukaryota.
DR   GeneTree; ENSGT00950000182849; -.
DR   HOGENOM; CLU_038627_1_0_1; -.
DR   InParanoid; Q9JJ19; -.
DR   OMA; ERESHQQ; -.
DR   OrthoDB; 2914289at2759; -.
DR   PhylomeDB; Q9JJ19; -.
DR   TreeFam; TF350449; -.
DR   PRO; PR:Q9JJ19; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003232; Expressed in jejunum and 20 other cell types or tissues.
DR   GO; GO:0045177; C:apical part of cell; ISO:RGD.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031526; C:brush border membrane; ISO:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:GOC.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005902; C:microvillus; ISO:RGD.
DR   GO; GO:0031528; C:microvillus membrane; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0098797; C:plasma membrane protein complex; IPI:ARUK-UCL.
DR   GO; GO:0001726; C:ruffle; IEA:UniProtKB-SubCell.
DR   GO; GO:0097225; C:sperm midpiece; ISS:UniProtKB.
DR   GO; GO:0032420; C:stereocilium; ISO:RGD.
DR   GO; GO:0032426; C:stereocilium tip; ISO:RGD.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; ISO:RGD.
DR   GO; GO:0099103; F:channel activator activity; ISO:RGD.
DR   GO; GO:0017081; F:chloride channel regulator activity; ISS:UniProtKB.
DR   GO; GO:0050780; F:dopamine receptor binding; ISO:RGD.
DR   GO; GO:0070851; F:growth factor receptor binding; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; IMP:RGD.
DR   GO; GO:0045159; F:myosin II binding; IDA:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0019902; F:phosphatase binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0043495; F:protein-membrane adaptor activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; ISO:RGD.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:RGD.
DR   GO; GO:0031799; F:type 2 metabotropic glutamate receptor binding; ISO:RGD.
DR   GO; GO:0031800; F:type 3 metabotropic glutamate receptor binding; ISO:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; ISO:RGD.
DR   GO; GO:0032782; P:bile acid secretion; ISS:UniProtKB.
DR   GO; GO:0090660; P:cerebrospinal fluid circulation; ISO:RGD.
DR   GO; GO:0044782; P:cilium organization; ISO:RGD.
DR   GO; GO:0045198; P:establishment of epithelial cell apical/basal polarity; ISO:RGD.
DR   GO; GO:0051683; P:establishment of Golgi localization; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0010761; P:fibroblast migration; ISO:RGD.
DR   GO; GO:0051939; P:gamma-aminobutyric acid import; IGI:ARUK-UCL.
DR   GO; GO:0022612; P:gland morphogenesis; ISO:RGD.
DR   GO; GO:0034635; P:glutathione transport; ISS:UniProtKB.
DR   GO; GO:0098739; P:import across plasma membrane; IGI:ARUK-UCL.
DR   GO; GO:0030643; P:intracellular phosphate ion homeostasis; ISO:RGD.
DR   GO; GO:0045199; P:maintenance of epithelial cell apical/basal polarity; ISO:RGD.
DR   GO; GO:0030033; P:microvillus assembly; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:2000146; P:negative regulation of cell motility; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010764; P:negative regulation of fibroblast migration; ISO:RGD.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; ISO:RGD.
DR   GO; GO:0051898; P:negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:UniProtKB.
DR   GO; GO:0010642; P:negative regulation of platelet-derived growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010766; P:negative regulation of sodium ion transport; ISO:RGD.
DR   GO; GO:0007097; P:nuclear migration; ISO:RGD.
DR   GO; GO:0060158; P:phospholipase C-activating dopamine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007009; P:plasma membrane organization; ISO:RGD.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0034767; P:positive regulation of monoatomic ion transmembrane transport; IDA:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0072659; P:protein localization to plasma membrane; ISO:RGD.
DR   GO; GO:0008360; P:regulation of cell shape; ISO:RGD.
DR   GO; GO:0008361; P:regulation of cell size; ISO:RGD.
DR   GO; GO:0045859; P:regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:1903402; P:regulation of renal phosphate excretion; ISO:RGD.
DR   GO; GO:0070293; P:renal absorption; ISS:UniProtKB.
DR   GO; GO:0097291; P:renal phosphate ion absorption; ISS:UniProtKB.
DR   GO; GO:0003096; P:renal sodium ion transport; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0006814; P:sodium ion transport; ISO:RGD.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd00992; PDZ_signaling; 2.
DR   Gene3D; 2.30.42.10; -; 2.
DR   InterPro; IPR015098; EBP50_C.
DR   InterPro; IPR051067; NHER.
DR   InterPro; IPR017300; NHERF-1/NHERF-2.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   PANTHER; PTHR14191:SF7; NA(+)_H(+) EXCHANGE REGULATORY COFACTOR NHE-RF1; 1.
DR   PANTHER; PTHR14191; PDZ DOMAIN CONTAINING PROTEIN; 1.
DR   Pfam; PF09007; EBP50_C; 1.
DR   Pfam; PF00595; PDZ; 2.
DR   PIRSF; PIRSF037866; EBP50; 1.
DR   SMART; SM00228; PDZ; 2.
DR   SUPFAM; SSF50156; PDZ domain-like; 2.
DR   PROSITE; PS50106; PDZ; 2.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Cell projection; Cytoplasm; Membrane;
KW   Phosphoprotein; Reference proteome; Repeat; Wnt signaling pathway.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O14745"
FT   CHAIN           2..356
FT                   /note="Na(+)/H(+) exchange regulatory cofactor NHE-RF1"
FT                   /id="PRO_0000096802"
FT   DOMAIN          14..94
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          151..231
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          113..142
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          265..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        306..320
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..346
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14745"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14745"
FT   MOD_RES         266
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14745"
FT   MOD_RES         277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         287
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         290
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         291
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   356 AA;  38830 MW;  C562AEF5870B8E08 CRC64;
     MSADAAAGEP LPRLCCLEKG PNGYGFHLHG EKGKVGQFIR LVEPGSPAEK SGLLAGDRLV
     EVNGENVEKE THQQVVSRIR AALNAVRLLV VDPETDEQLK KLGVPIREEL LRAQEKSEHT
     EPPAAADTKK AGDQNEAEKS HLERCELRPR LCTMKKGPNG YGFNLHSDKS KPGQFIRAVD
     PDSPAEASGL RAQDRIVEVN GVCMEGKQHG DVVSAIKAGG DEAKLLVVDK ETDEFFKKCR
     VTPSQEHLDG PLPEPFSNGE IQKENSREAL VEPASESPRP ALARSASSDT SEELNAQDSP
     KRHDSTEPSS TSSSSDPILD FNISLAVAKE RAHQKRSSKR APQMDWSKKN ELFSNL
//
